These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 35247611)

  • 21. Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2.
    Zhu W; Sahar NE; Javaid HMA; Pak ES; Liang G; Wang Y; Ha H; Huh JY
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE
    Feng D; Zou J; Su D; Mai H; Zhang S; Li P; Zheng X
    Nutr Metab (Lond); 2019; 16():79. PubMed ID: 31788011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease.
    Zhang C; Chen F; Feng L; Shan Q; Zheng GH; Wang YJ; Lu J; Fan SH; Sun CH; Wu DM; Li MQ; Hu B; Wang QQ; Zhang ZF; Zheng YL
    Mol Med; 2019 Jun; 25(1):29. PubMed ID: 31215394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
    Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
    Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway.
    Chen J; Yang S; Luo H; Fu X; Li W; Li B; Fu C; Chen F; Xu D; Cao N
    Int Immunopharmacol; 2024 Nov; 141():113014. PubMed ID: 39191120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease.
    Wu H; Zhou M; Jin Q; Wang X; Xu Y; Li M; Chen S; Tang Q; Wang Q; Hu B; Wu H; Xiao M; Qu L; Zhang Q; Liu J
    Hepatol Int; 2024 Aug; 18(4):1144-1157. PubMed ID: 38184503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltration.
    Zhang Y; Zhou X; Liu P; Chen X; Zhang J; Zhang H; Li S; Chen Y; Song X; Wang J; Zeng H; Zhang X; Tang C; Yu C; Li Y; Xu C
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G531-G542. PubMed ID: 33470903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.
    Ye D; Li FY; Lam KS; Li H; Jia W; Wang Y; Man K; Lo CM; Li X; Xu A
    Gut; 2012 Jul; 61(7):1058-67. PubMed ID: 22253482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. iRhom2 Promotes Hepatic Steatosis by Activating MAP3K7-Dependent Pathway.
    Xu M; Ge C; Zhu L; Qin Y; Du C; Lou D; Li Q; Hu L; Sun Y; Dai X; Xiong M; Long T; Zhan J; Kuang Q; Li H; Yang Q; Huang P; Teng X; Feng J; Wu Y; Dong W; Wang B; Tan J
    Hepatology; 2021 Apr; 73(4):1346-1364. PubMed ID: 32592194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
    Pan ZG; An XS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice.
    Hao YR; Tang FJ; Zhang X; Wang H
    Biochem Biophys Res Commun; 2018 Sep; 503(2):564-571. PubMed ID: 29852170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum amyloid A1 levels and amyloid deposition following a high-fat diet challenge in transgenic mice overexpressing hepatic serum amyloid A1.
    Jang WY; Jeong J; Kim S; Kang MC; Sung YH; Choi M; Park SJ; Kim MO; Kim SH; Ryoo ZY
    Appl Physiol Nutr Metab; 2016 Jun; 41(6):640-8. PubMed ID: 27218680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic TLR4 signaling in obese NAFLD.
    Sharifnia T; Antoun J; Verriere TG; Suarez G; Wattacheril J; Wilson KT; Peek RM; Abumrad NN; Flynn CR
    Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(4):G270-8. PubMed ID: 26113297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
    Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
    Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.
    Wang L; Jia Z; Wang B; Zhang B
    Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JIP3 knockout protects mice against high fat diet-induced liver injury.
    Ma XJ; Xing HZ; Ren GF; Rao XJ; Li ZZ
    Biochem Biophys Res Commun; 2018 Mar; 497(3):819-826. PubMed ID: 29454969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress.
    Li C; Liu Q; Xie L
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):22-29. PubMed ID: 30454891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of AMPKα2 in the HFD-induced nonalcoholic steatohepatitis.
    Zhang X; Liu S; Zhang C; Zhang S; Yue Y; Zhang Y; Chen L; Yao Z; Niu W
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165854. PubMed ID: 32502647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice.
    Diniz TA; de Lima Junior EA; Teixeira AA; Biondo LA; da Rocha LAF; Valadão IC; Silveira LS; Cabral-Santos C; de Souza CO; Rosa Neto JC
    Life Sci; 2021 Feb; 266():118868. PubMed ID: 33310034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver.
    Tian Y; Ma J; Wang W; Zhang L; Xu J; Wang K; Li D
    Mol Cell Biochem; 2016 Nov; 422(1-2):75-84. PubMed ID: 27613163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.